+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The effect of ursodeoxycholic acid udca on liver function and bile acid metabolism in patients with cystic fibrosis cf and liver disease



The effect of ursodeoxycholic acid udca on liver function and bile acid metabolism in patients with cystic fibrosis cf and liver disease



Hepatology 10(4): 726




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 033786964

Download citation: RISBibTeXText


Related references

Effect of ursodeoxycholic acid (UDCA) therapy for compensatory liver cirrhosis on liver function tests and serum bile acid metabolism. Nihon Shokakibyo Gakkai Zasshi 89(12): 2762-2770, 1992

A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease. Hepatology 27(1): 166-174, 1998

Ursodeoxycholic acid udca therapy in patients with cystic fibrosis cf and liver disease a dose response study. Gastroenterology 100(5 PART 2): A731, 1991

Ursodeoxycholic acid udca treatment improves liver disease and nutritional state in cystic fibrosis cf patients with chronic cholestasis. Gastroenterology 96(5 PART 2): A586, 1989

Effects of ursodeoxycholic acid udca on liver function tests and bile acid metabolism in anicteric primary biliary cirrhosis pbc a dose response study. Hepatology 8(5): 1266, 1988

Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration. Hepatology 12(2): 322-334, 1990

Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis. Hepatology 23(6): 1484-1490, 1996

Markedly decreased biliary ursodeoxycholic acid enrichment with high dose UDCA in cystic fibrosis associated liver disease Optimization of the therapeutic dose. Hepatology 20(4 PART 2): 262A, 1994

Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease. European Journal of Gastroenterology and Hepatology 8(5): 477-483, 1996

Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease. Hepatology 15(4): 677-684, 1992

Effect of ursodeoxycholic acid udca on liver function lf in patients with chronic active hepatitis and cirrhosis. European Journal of Clinical Investigation 20(2 PART 2): A62, 1990

Long-Term Ursodeoxycholic Acid Therapy Does Not Alter Lithocholic Acid Levels in Patients with Cystic Fibrosis with Associated Liver Disease. Journal of Pediatrics 177: 59-65.E1, 2017

Treatment with ursodeoxycholic acid for patients with cystic fibrosis and liver disease. Escobar, H, Baquero, F, Suarez, L International Congress Series; Clinical ecology of cystic fibrosis 275-279, 1993

Effects of ursodeoxycholic acid on liver function in patients with cystic fibrosis and chronic cholestasis. Journal of Pediatrics 121(1): 138-141, 1992

Effects of taurine and ursodeoxycholic acid on liver function tests in patients with cystic fibrosis. Acta Universitatis Carolinae. Medica 36(1-4): 148-151, 1990